‘Rush To Downsize’ Is A Danger To NCI, Broder Warns In A Farewell Address
In Brief: NBCC Wins Grants To Train Breast Cancer Activists In Language, Concepts Of Science
Latest Statistics Show Decline In Deaths From Breast Cancer
“What Is Good For NCI Is Good For NIH,” Broder Says In Address
Proposed Deal Could Resolve Key Disputes At NSABP, Pitt
NIH Reconsiders Closing A Meeting Of Advisory Group
NIH Extramural Office Lists Initiatives For Reinvention
Trending Stories
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Peter F. Garrett to people with cancer: Your story has power
- OMB proposed rule could end 50% of currently active clinical trials, Stand up for Science analysis finds
- Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.” - What NHS-Galleri taught us—and what it didn’t
- The NHS-Galleri trial has and will continue to provide critical insights to refine future MCED studies









